Carole S. Ben-Maimon
2013 - Impax Laboratories
In 2013, Carole S. Ben-Maimon earned a total compensation of $1.8M as Former President, Impax Generics Division at Impax Laboratories, a 57% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $431,246 |
|---|---|
| Option Awards | $392,075 |
| Salary | $486,257 |
| Stock Awards | $446,152 |
| Other | $31,962 |
| Total | $1,787,692 |
Ben-Maimon received $486.3K in salary, accounting for 27% of the total pay in 2013.
Ben-Maimon also received $431.2K in non-equity incentive plan, $392.1K in option awards, $446.2K in stock awards and $32K in other compensation.
Rankings
In 2013, Carole S. Ben-Maimon's compensation ranked 4,263rd out of 12,286 executives tracked by ExecPay. In other words, Ben-Maimon earned more than 65.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,263 out of 12,286 | 65th |
Division Manufacturing | 1,455 out of 4,612 | 69th |
Major group Chemicals And Allied Products | 403 out of 1,462 | 72nd |
Industry group Drugs | 278 out of 1,156 | 76th |
Industry Pharmaceutical Preparations | 226 out of 890 | 75th |
Source: SEC filing on April 14, 2015.
Ben-Maimon's colleagues
We found four more compensation records of executives who worked with Carole S. Ben-Maimon at Impax Laboratories in 2013.